nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Lactulose—Acarbose—type 2 diabetes mellitus	0.167	0.202	CrCrCtD
Tobramycin—Framycetin—Acarbose—type 2 diabetes mellitus	0.147	0.179	CrCrCtD
Tobramycin—Neomycin—Acarbose—type 2 diabetes mellitus	0.147	0.179	CrCrCtD
Tobramycin—Paromomycin—Acarbose—type 2 diabetes mellitus	0.132	0.16	CrCrCtD
Tobramycin—Amikacin—Acarbose—type 2 diabetes mellitus	0.121	0.146	CrCrCtD
Tobramycin—Kanamycin—Acarbose—type 2 diabetes mellitus	0.111	0.134	CrCrCtD
Tobramycin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00014	0.0008	CcSEcCtD
Tobramycin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00014	0.000799	CcSEcCtD
Tobramycin—Rash—Glipizide—type 2 diabetes mellitus	0.000139	0.000796	CcSEcCtD
Tobramycin—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000139	0.000795	CcSEcCtD
Tobramycin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000139	0.000795	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000139	0.000794	CcSEcCtD
Tobramycin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000139	0.000794	CcSEcCtD
Tobramycin—Erythema—Losartan—type 2 diabetes mellitus	0.000139	0.000794	CcSEcCtD
Tobramycin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000138	0.000792	CcSEcCtD
Tobramycin—Headache—Glipizide—type 2 diabetes mellitus	0.000138	0.00079	CcSEcCtD
Tobramycin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000137	0.000786	CcSEcCtD
Tobramycin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000137	0.000784	CcSEcCtD
Tobramycin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000137	0.000783	CcSEcCtD
Tobramycin—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000137	0.000783	CcSEcCtD
Tobramycin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000136	0.00078	CcSEcCtD
Tobramycin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000136	0.000779	CcSEcCtD
Tobramycin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000136	0.000778	CcSEcCtD
Tobramycin—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000136	0.000777	CcSEcCtD
Tobramycin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000136	0.000777	CcSEcCtD
Tobramycin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000136	0.000776	CcSEcCtD
Tobramycin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000135	0.000776	CcSEcCtD
Tobramycin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000135	0.000771	CcSEcCtD
Tobramycin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000135	0.000771	CcSEcCtD
Tobramycin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000134	0.000769	CcSEcCtD
Tobramycin—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000134	0.000768	CcSEcCtD
Tobramycin—Back pain—Losartan—type 2 diabetes mellitus	0.000134	0.000768	CcSEcCtD
Tobramycin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000134	0.000768	CcSEcCtD
Tobramycin—Anorexia—Valsartan—type 2 diabetes mellitus	0.000133	0.000764	CcSEcCtD
Tobramycin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000133	0.000762	CcSEcCtD
Tobramycin—Chest pain—Metformin—type 2 diabetes mellitus	0.000133	0.000761	CcSEcCtD
Tobramycin—Myalgia—Metformin—type 2 diabetes mellitus	0.000133	0.000761	CcSEcCtD
Tobramycin—Malaise—Irbesartan—type 2 diabetes mellitus	0.000133	0.000761	CcSEcCtD
Tobramycin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000132	0.000758	CcSEcCtD
Tobramycin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000132	0.000757	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000132	0.000756	CcSEcCtD
Tobramycin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000755	CcSEcCtD
Tobramycin—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000132	0.000754	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000131	0.000753	CcSEcCtD
Tobramycin—Discomfort—Metformin—type 2 diabetes mellitus	0.000131	0.000752	CcSEcCtD
Tobramycin—Nausea—Glipizide—type 2 diabetes mellitus	0.000131	0.00075	CcSEcCtD
Tobramycin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000131	0.000749	CcSEcCtD
Tobramycin—Vision blurred—Losartan—type 2 diabetes mellitus	0.000131	0.000748	CcSEcCtD
Tobramycin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000746	CcSEcCtD
Tobramycin—Pain—Gliclazide—type 2 diabetes mellitus	0.00013	0.000746	CcSEcCtD
Tobramycin—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.000742	CcSEcCtD
Tobramycin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000129	0.000742	CcSEcCtD
Tobramycin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000129	0.00074	CcSEcCtD
Tobramycin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000739	CcSEcCtD
Tobramycin—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.000738	CcSEcCtD
Tobramycin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000129	0.000737	CcSEcCtD
Tobramycin—Cough—Irbesartan—type 2 diabetes mellitus	0.000128	0.000736	CcSEcCtD
Tobramycin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000128	0.000735	CcSEcCtD
Tobramycin—Anaemia—Losartan—type 2 diabetes mellitus	0.000128	0.000734	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000127	0.00073	CcSEcCtD
Tobramycin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000127	0.000729	CcSEcCtD
Tobramycin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000727	CcSEcCtD
Tobramycin—Angioedema—Losartan—type 2 diabetes mellitus	0.000127	0.000725	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000126	0.000721	CcSEcCtD
Tobramycin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000126	0.000719	CcSEcCtD
Tobramycin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000125	0.000719	CcSEcCtD
Tobramycin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.000718	CcSEcCtD
Tobramycin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000718	CcSEcCtD
Tobramycin—Malaise—Losartan—type 2 diabetes mellitus	0.000125	0.000716	CcSEcCtD
Tobramycin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000125	0.000715	CcSEcCtD
Tobramycin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000125	0.000715	CcSEcCtD
Tobramycin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000125	0.000714	CcSEcCtD
Tobramycin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000125	0.000714	CcSEcCtD
Tobramycin—Vertigo—Losartan—type 2 diabetes mellitus	0.000124	0.000713	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000124	0.000713	CcSEcCtD
Tobramycin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.000713	CcSEcCtD
Tobramycin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000124	0.000711	CcSEcCtD
Tobramycin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000124	0.000711	CcSEcCtD
Tobramycin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000124	0.00071	CcSEcCtD
Tobramycin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000124	0.000709	CcSEcCtD
Tobramycin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000123	0.000706	CcSEcCtD
Tobramycin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000123	0.000705	CcSEcCtD
Tobramycin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000702	CcSEcCtD
Tobramycin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000122	0.000699	CcSEcCtD
Tobramycin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000697	CcSEcCtD
Tobramycin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000122	0.000697	CcSEcCtD
Tobramycin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000122	0.000696	CcSEcCtD
Tobramycin—Anorexia—Metformin—type 2 diabetes mellitus	0.000121	0.000695	CcSEcCtD
Tobramycin—Cough—Losartan—type 2 diabetes mellitus	0.000121	0.000693	CcSEcCtD
Tobramycin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000121	0.000693	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000692	CcSEcCtD
Tobramycin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00012	0.000689	CcSEcCtD
Tobramycin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00012	0.000689	CcSEcCtD
Tobramycin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00012	0.000689	CcSEcCtD
Tobramycin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00012	0.000688	CcSEcCtD
Tobramycin—Pruritus—Glyburide—type 2 diabetes mellitus	0.00012	0.000687	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000119	0.000683	CcSEcCtD
Tobramycin—Erythema—Ramipril—type 2 diabetes mellitus	0.000119	0.000681	CcSEcCtD
Tobramycin—Pain—Orlistat—type 2 diabetes mellitus	0.000118	0.000677	CcSEcCtD
Tobramycin—Chest pain—Losartan—type 2 diabetes mellitus	0.000118	0.000676	CcSEcCtD
Tobramycin—Myalgia—Losartan—type 2 diabetes mellitus	0.000118	0.000676	CcSEcCtD
Tobramycin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000675	CcSEcCtD
Tobramycin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000118	0.000675	CcSEcCtD
Tobramycin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000674	CcSEcCtD
Tobramycin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000117	0.00067	CcSEcCtD
Tobramycin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000669	CcSEcCtD
Tobramycin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000669	CcSEcCtD
Tobramycin—Discomfort—Losartan—type 2 diabetes mellitus	0.000117	0.000668	CcSEcCtD
Tobramycin—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000116	0.000667	CcSEcCtD
Tobramycin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000665	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.000665	CcSEcCtD
Tobramycin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000116	0.000664	CcSEcCtD
Tobramycin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000656	CcSEcCtD
Tobramycin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.000655	CcSEcCtD
Tobramycin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000114	0.000655	CcSEcCtD
Tobramycin—Confusional state—Losartan—type 2 diabetes mellitus	0.000114	0.000653	CcSEcCtD
Tobramycin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000114	0.000652	CcSEcCtD
Tobramycin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000114	0.00065	CcSEcCtD
Tobramycin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000113	0.000648	CcSEcCtD
Tobramycin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000647	CcSEcCtD
Tobramycin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000112	0.000642	CcSEcCtD
Tobramycin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000111	0.000636	CcSEcCtD
Tobramycin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000111	0.000635	CcSEcCtD
Tobramycin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000111	0.000634	CcSEcCtD
Tobramycin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000111	0.000634	CcSEcCtD
Tobramycin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000111	0.000633	CcSEcCtD
Tobramycin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000632	CcSEcCtD
Tobramycin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000631	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00011	0.00063	CcSEcCtD
Tobramycin—Urticaria—Orlistat—type 2 diabetes mellitus	0.00011	0.000629	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000109	0.000627	CcSEcCtD
Tobramycin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000109	0.000626	CcSEcCtD
Tobramycin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000109	0.000626	CcSEcCtD
Tobramycin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000109	0.000626	CcSEcCtD
Tobramycin—Angioedema—Ramipril—type 2 diabetes mellitus	0.000109	0.000622	CcSEcCtD
Tobramycin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000618	CcSEcCtD
Tobramycin—Anorexia—Losartan—type 2 diabetes mellitus	0.000108	0.000618	CcSEcCtD
Tobramycin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000108	0.000617	CcSEcCtD
Tobramycin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000617	CcSEcCtD
Tobramycin—Malaise—Ramipril—type 2 diabetes mellitus	0.000107	0.000614	CcSEcCtD
Tobramycin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000614	CcSEcCtD
Tobramycin—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000612	CcSEcCtD
Tobramycin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000612	CcSEcCtD
Tobramycin—Vertigo—Ramipril—type 2 diabetes mellitus	0.000107	0.000612	CcSEcCtD
Tobramycin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000106	0.000609	CcSEcCtD
Tobramycin—Headache—Glyburide—type 2 diabetes mellitus	0.000106	0.000608	CcSEcCtD
Tobramycin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000105	0.000601	CcSEcCtD
Tobramycin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000104	0.000599	CcSEcCtD
Tobramycin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000104	0.000597	CcSEcCtD
Tobramycin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000597	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.000594	CcSEcCtD
Tobramycin—Cough—Ramipril—type 2 diabetes mellitus	0.000104	0.000594	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.00059	CcSEcCtD
Tobramycin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000103	0.00059	CcSEcCtD
Tobramycin—Pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000589	CcSEcCtD
Tobramycin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000102	0.000583	CcSEcCtD
Tobramycin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000102	0.000582	CcSEcCtD
Tobramycin—Urticaria—Metformin—type 2 diabetes mellitus	0.000101	0.00058	CcSEcCtD
Tobramycin—Myalgia—Ramipril—type 2 diabetes mellitus	0.000101	0.00058	CcSEcCtD
Tobramycin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000101	0.00058	CcSEcCtD
Tobramycin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000101	0.000578	CcSEcCtD
Tobramycin—Nausea—Glyburide—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Tobramycin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Tobramycin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.0001	0.000576	CcSEcCtD
Tobramycin—Asthenia—Valsartan—type 2 diabetes mellitus	0.0001	0.000575	CcSEcCtD
Tobramycin—Discomfort—Ramipril—type 2 diabetes mellitus	9.99e-05	0.000573	CcSEcCtD
Tobramycin—Asthenia—Orlistat—type 2 diabetes mellitus	9.91e-05	0.000568	CcSEcCtD
Tobramycin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.9e-05	0.000567	CcSEcCtD
Tobramycin—Pruritus—Valsartan—type 2 diabetes mellitus	9.89e-05	0.000567	CcSEcCtD
Tobramycin—Decreased appetite—Losartan—type 2 diabetes mellitus	9.83e-05	0.000563	CcSEcCtD
Tobramycin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000563	CcSEcCtD
Tobramycin—Confusional state—Ramipril—type 2 diabetes mellitus	9.78e-05	0.00056	CcSEcCtD
Tobramycin—Pruritus—Orlistat—type 2 diabetes mellitus	9.78e-05	0.00056	CcSEcCtD
Tobramycin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000556	CcSEcCtD
Tobramycin—Vomiting—Gliclazide—type 2 diabetes mellitus	9.68e-05	0.000554	CcSEcCtD
Tobramycin—Pain—Losartan—type 2 diabetes mellitus	9.67e-05	0.000554	CcSEcCtD
Tobramycin—Rash—Gliclazide—type 2 diabetes mellitus	9.6e-05	0.00055	CcSEcCtD
Tobramycin—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.59e-05	0.000549	CcSEcCtD
Tobramycin—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.57e-05	0.000548	CcSEcCtD
Tobramycin—Urticaria—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000547	CcSEcCtD
Tobramycin—Headache—Gliclazide—type 2 diabetes mellitus	9.53e-05	0.000546	CcSEcCtD
Tobramycin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000545	CcSEcCtD
Tobramycin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000544	CcSEcCtD
Tobramycin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000544	CcSEcCtD
Tobramycin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000544	CcSEcCtD
Tobramycin—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.45e-05	0.000542	CcSEcCtD
Tobramycin—Skin disorder—Ramipril—type 2 diabetes mellitus	9.42e-05	0.00054	CcSEcCtD
Tobramycin—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.32e-05	0.000534	CcSEcCtD
Tobramycin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.25e-05	0.00053	CcSEcCtD
Tobramycin—Dizziness—Valsartan—type 2 diabetes mellitus	9.25e-05	0.00053	CcSEcCtD
Tobramycin—Anorexia—Ramipril—type 2 diabetes mellitus	9.24e-05	0.00053	CcSEcCtD
Tobramycin—Dizziness—Orlistat—type 2 diabetes mellitus	9.14e-05	0.000524	CcSEcCtD
Tobramycin—Asthenia—Metformin—type 2 diabetes mellitus	9.14e-05	0.000523	CcSEcCtD
Tobramycin—Nausea—Gliclazide—type 2 diabetes mellitus	9.04e-05	0.000518	CcSEcCtD
Tobramycin—Pruritus—Metformin—type 2 diabetes mellitus	9.01e-05	0.000516	CcSEcCtD
Tobramycin—Urticaria—Losartan—type 2 diabetes mellitus	8.98e-05	0.000515	CcSEcCtD
Tobramycin—Abdominal pain—Losartan—type 2 diabetes mellitus	8.94e-05	0.000512	CcSEcCtD
Tobramycin—Body temperature increased—Losartan—type 2 diabetes mellitus	8.94e-05	0.000512	CcSEcCtD
Tobramycin—Vomiting—Valsartan—type 2 diabetes mellitus	8.89e-05	0.000509	CcSEcCtD
Tobramycin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.85e-05	0.000507	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000506	CcSEcCtD
Tobramycin—Rash—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000505	CcSEcCtD
Tobramycin—Dermatitis—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000505	CcSEcCtD
Tobramycin—Vomiting—Orlistat—type 2 diabetes mellitus	8.79e-05	0.000503	CcSEcCtD
Tobramycin—Headache—Valsartan—type 2 diabetes mellitus	8.76e-05	0.000502	CcSEcCtD
Tobramycin—Diarrhoea—Metformin—type 2 diabetes mellitus	8.71e-05	0.000499	CcSEcCtD
Tobramycin—Rash—Orlistat—type 2 diabetes mellitus	8.71e-05	0.000499	CcSEcCtD
Tobramycin—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000499	CcSEcCtD
Tobramycin—Dermatitis—Orlistat—type 2 diabetes mellitus	8.7e-05	0.000499	CcSEcCtD
Tobramycin—Headache—Orlistat—type 2 diabetes mellitus	8.66e-05	0.000496	CcSEcCtD
Tobramycin—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000495	CcSEcCtD
Tobramycin—Asthenia—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000494	CcSEcCtD
Tobramycin—Pruritus—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000487	CcSEcCtD
Tobramycin—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000483	CcSEcCtD
Tobramycin—Dizziness—Metformin—type 2 diabetes mellitus	8.42e-05	0.000482	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.37e-05	0.00048	CcSEcCtD
Tobramycin—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.33e-05	0.000477	CcSEcCtD
Tobramycin—Nausea—Valsartan—type 2 diabetes mellitus	8.31e-05	0.000476	CcSEcCtD
Tobramycin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.22e-05	0.000471	CcSEcCtD
Tobramycin—Nausea—Orlistat—type 2 diabetes mellitus	8.21e-05	0.00047	CcSEcCtD
Tobramycin—Asthenia—Losartan—type 2 diabetes mellitus	8.11e-05	0.000465	CcSEcCtD
Tobramycin—Vomiting—Metformin—type 2 diabetes mellitus	8.1e-05	0.000464	CcSEcCtD
Tobramycin—Rash—Metformin—type 2 diabetes mellitus	8.03e-05	0.00046	CcSEcCtD
Tobramycin—Dermatitis—Metformin—type 2 diabetes mellitus	8.02e-05	0.00046	CcSEcCtD
Tobramycin—Pruritus—Losartan—type 2 diabetes mellitus	8e-05	0.000458	CcSEcCtD
Tobramycin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.99e-05	0.000458	CcSEcCtD
Tobramycin—Headache—Metformin—type 2 diabetes mellitus	7.98e-05	0.000457	CcSEcCtD
Tobramycin—Dizziness—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000455	CcSEcCtD
Tobramycin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000454	CcSEcCtD
Tobramycin—Diarrhoea—Losartan—type 2 diabetes mellitus	7.74e-05	0.000443	CcSEcCtD
Tobramycin—Urticaria—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000441	CcSEcCtD
Tobramycin—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000439	CcSEcCtD
Tobramycin—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000439	CcSEcCtD
Tobramycin—Vomiting—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000438	CcSEcCtD
Tobramycin—Rash—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000434	CcSEcCtD
Tobramycin—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000434	CcSEcCtD
Tobramycin—Nausea—Metformin—type 2 diabetes mellitus	7.56e-05	0.000433	CcSEcCtD
Tobramycin—Headache—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000431	CcSEcCtD
Tobramycin—Dizziness—Losartan—type 2 diabetes mellitus	7.48e-05	0.000428	CcSEcCtD
Tobramycin—Vomiting—Losartan—type 2 diabetes mellitus	7.19e-05	0.000412	CcSEcCtD
Tobramycin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000409	CcSEcCtD
Tobramycin—Nausea—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000409	CcSEcCtD
Tobramycin—Rash—Losartan—type 2 diabetes mellitus	7.13e-05	0.000409	CcSEcCtD
Tobramycin—Dermatitis—Losartan—type 2 diabetes mellitus	7.12e-05	0.000408	CcSEcCtD
Tobramycin—Headache—Losartan—type 2 diabetes mellitus	7.08e-05	0.000406	CcSEcCtD
Tobramycin—Asthenia—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000399	CcSEcCtD
Tobramycin—Pruritus—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000393	CcSEcCtD
Tobramycin—Nausea—Losartan—type 2 diabetes mellitus	6.72e-05	0.000385	CcSEcCtD
Tobramycin—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.64e-05	0.00038	CcSEcCtD
Tobramycin—Dizziness—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000367	CcSEcCtD
Tobramycin—Vomiting—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000353	CcSEcCtD
Tobramycin—Rash—Ramipril—type 2 diabetes mellitus	6.11e-05	0.00035	CcSEcCtD
Tobramycin—Dermatitis—Ramipril—type 2 diabetes mellitus	6.11e-05	0.00035	CcSEcCtD
Tobramycin—Headache—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000348	CcSEcCtD
Tobramycin—Nausea—Ramipril—type 2 diabetes mellitus	5.76e-05	0.00033	CcSEcCtD
